Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the egf receptor

International Journal of Cancer

Volumn 43, Issue 1, 1989, Pages 152-157

  Ozawa, Soji ^a   Ueda, Masakazu ^a   Ando, Nobutoshi ^a   Abe, Osahiko ^a   Minoshima, Shinsei ^a   Shimizu, Nobuyoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; ANTITOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELONIN; MONOCLONAL ANTIBODY;

CARCINOMA CELL; CELL CULTURE; CYTOTOXICITY; DRUG TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMAL; CARCINOMA, SQUAMOUS CELL; CELL LINE; FLOW CYTOMETRY; HUMAN; IMMUNIZATION, PASSIVE; IMMUNOTOXINS; MICE; PLANT PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T;

EID: 0024586031     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910430128     Document Type: Article

References (28)

1. Potentiation of cytotoxic activity of immunotoxins on cultured human cells
2. Ribosome‐Inactivating proteins from plants: properties and possible uses
3. Monoclonal antibody that immunoreacts with a subclass of human receptors for epidermal growth factor
4. Variant of A431 cells isolated by ricin A‐Conjugated monoclonal antibody directed to EGF receptor: phosphatidtlatiositol
5. Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins
6. In vitro and in in vivo effects of a monoelonal antibody‐Toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer
7. The amount of EGF receptor is elevated on squamous cell carcinomas
8. Selective destruction of nene growth factor receptor‐Bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor
9. Properties of the ribosome‐Inactivating proteins gelonin, Momordica charantica inhibitor, and dianthins
10. Prospects for immunotoxin therapy in cancer
11. Monoclonal antibody‐Ricin A chain conjugates (immunotoxins): potential therapeutic agents for human colon carcinoma
12. Antibody‐Directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells
13. Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas
14. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
15. Purified immunotoxins that are reactive with human lymphoid cells: monoclonal antibodies conjugated to the ribosome‐Inactivating proteins gelonin and the pokeweed antiviral proteins
16. An immunotoxin cytotoxic for breast cancer cells in vitro
17. Uptake of epidermal growth factor into a lysosomal enzyme‐Deficient organelle: correlation with cell's mitogenic response and evidence for ubiquitous existence in fibroblasts
18. An antibodytoxin conjugate directed against a human mammary cancer antigen
19. Stimulation by EGF of the growth of EGF receptor‐Hyperproducing tumor cells in athymic mice
20. High incidence of EGF receptor hyperproduction in esophageal squamous‐Cell carcinomas
21. Characterization of immunotoxins active against ovarian cancer cell lines
22. Anti‐Transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines
23. EGF‐Ricin A conjugates: kinetic profiles of cytotoxic effects and resistant cell variants
24. Gelonin, a new inhibitor of protein synthesis, non‐Toxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A
25. A receptor group delivery system with both absolute and selective specificity for thiol groups and an improved fluorescent probe containing the 7‐Nitrobenzo‐2‐Oxa‐1,3‐Diazole moiety
26. In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma
27. Selective killing of laryngeal carcinoma cells by a monoclonal immunotoxin
28. Potent and specific killing of human malignant brain‐Tumor cells by an anti‐Transferrin receptor antibody‐Ricin immunotoxin